https://www.forpatients.roche.co.za2026-01-14https://www.forpatients.roche.co.za/en/trials.html2025-06-11https://www.forpatients.roche.co.za/en/trials/uncategorized.html2019-04-26https://www.forpatients.roche.co.za/en/trials/uncategorized/atezolizumab-consolidation-in-limited-stage-small-cell--22210.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/bc/a-european-registry-study-to-prospectively-observe-treatment-pat.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-multiple--68522.html2024-03-13https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-of-ipatasertib-in-combination-with-paclitaxel-as-a-treat.html2024-08-31https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-of-atezolizumab-and-paclitaxel-versus-placebo-and-paclit.html2024-08-30https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-of-the-efficacy-and-safety-of-atezolizumab-plus-chemothe.html2024-11-09https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-of-trastuzumab-emtansine-versus-trastuzumab-as-adjuvant-.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-9545--37336.html2024-09-21https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-adjuvant--58545.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-to-evaluate-patient-preference-for-home-adminis-86302.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/the-purpose-of-this-study-is-to-evaluate-the-efficacy-a-74702.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-giredestr-26550.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-of-ro7247669---nab-paclitaxel-compared-with-pem-15706.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-04316.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-to-evaluate-the-efficacy-and-safety-of-giredest-09790.html2025-03-29https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-to-evaluate-efficacy-and-safety-of-giredestrant-50902.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/bc/a-study-of-pertuzumab-in-addition-to-chemotherapy-and-t-28091.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/leukemia/a-study-to-compare-the-efficacy-and-safety-of-obinutuzu-46860.html2024-03-13https://www.forpatients.roche.co.za/en/trials/cancer/leukemia/a-study-evaluating-the-safety--efficacy--and-pharmacoki-80734.html2024-03-13https://www.forpatients.roche.co.za/en/trials/cancer/oc/an-observational-study-of-avastin--bevacizumab--in-pati-15217.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/crc.html2023-05-10https://www.forpatients.roche.co.za/en/trials/cancer/pv.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cancer/bladder-cancer/study-of-atezolizumab-as-monotherapy-and-in-combination-with-pla.html2025-02-25https://www.forpatients.roche.co.za/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-combination-with-carboplatin-17822.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-98469.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/lung-cancer/acceleret-lung-study-of-pralsetinib-for-1l-ret-fusion-p-70294.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/lung-cancer/a-study-to-evaluate-efficacy-and-safety-of-multiple-targeted-the.html2024-03-13https://www.forpatients.roche.co.za/en/trials/cancer/lung-cancer/a-study-of-multiple-immunotherapy-based-treatment-combinations-i0.html2024-03-13https://www.forpatients.roche.co.za/en/trials/cancer/lung-cancer/a-study-of-neoadjuvant-atezolizumab-plus-chemotherapy-versus-pla.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/lung-cancer/a-study-to-investigate-the-pharmacokinetics--efficacy---50110.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/multiple-myeloma.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cancer/multiple-myeloma/a-study-of-cobimetinib-administered-as-single-agent-and-in-combi.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/rcc.html2023-05-10https://www.forpatients.roche.co.za/en/trials/cancer/skin-cancer/atezolizumab-in-combination-with-bevacizumab-in-patient-26747.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/skin-cancer/cobimetinib--targeted-therapy--plus-atezolizumab--immunotherapy-.html2026-03-25https://www.forpatients.roche.co.za/en/trials/cancer/hepatocellular-carcinoma/a-study-evaluating-atezolizumab-and-bevacizumab--with-o-66135.html2025-03-27https://www.forpatients.roche.co.za/en/trials/cancer/Head_and_Neck_Cancer/a-study-of-atezolizumab--antipd-l1-antibody--as-adjuvant-therapy.html2024-10-10https://www.forpatients.roche.co.za/en/trials/cancer/Brain_Tumor.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cancer/pancreatic-cancer.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cancer/pancreatic-cancer/a-study-of-multiple-immunotherapy-based-treatment-combinations-i2.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/an-extension--rollover--study-of-vemurafenib-in-participants-wit.html2024-08-30https://www.forpatients.roche.co.za/en/trials/cancer/prostate-cancer.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cancer/gc.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cancer/fmi.html2023-05-10https://www.forpatients.roche.co.za/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety-and-efficacy-of-polatuzu-71789.html2024-03-13https://www.forpatients.roche.co.za/en/trials/cancer/non-hodgkins-lymphoma/a-study-of-ro7082859-in-combination-with-rituximab-or-obinutuzum.htmlhttps://www.forpatients.roche.co.za/en/trials/cancer/endometrial-cancer.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cancer/solid-tumors/an-open-label-dose-escalation-study-to-evaluate-xmab243-88679.html2024-03-13https://www.forpatients.roche.co.za/en/trials/cancer/high-grade-glioma.html2020-09-01https://www.forpatients.roche.co.za/en/trials/cancer/esophageal-squamous-cell-carcinoma/a-study-of-atezolizumab-with-or-without-tiragolumab-in--42508.html2025-04-11https://www.forpatients.roche.co.za/en/trials/cancer/an-extension-study-to-provide-continued-bevacizumab-therapy-to-p.html2024-08-30https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/giant-cell-arteritis.html2019-12-18https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/jia.html2019-04-26https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/ra.html2019-04-26https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/sjogren-s-syndrome.html2019-04-26https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/ulcerative-colitis/study-for-participants-with-ulcerative-colitis-previously-enroll.html2024-10-24https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-of-the-efficacy-and-safety-of-etrolizumab-treatment-in-m.html2024-08-30https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-comparing-the-efficacy-and-safety-of-etrolizumab-to-infl.html2024-09-01https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/crohn-s-disease/open-label-extension-and-safety-study-for-patients-with-crohn-s-.html2024-12-03https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-whether-etrolizumab-is-a-safe-and-effective-tr.html2024-08-31https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/sle/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-62318.html2025-03-27https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/sle/a-first-in-human-study-to-investigate-the-safety--toler-46873.html2025-11-18https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/systemic-sclerosis.html2019-04-26https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-33293.html2025-03-27https://www.forpatients.roche.co.za/en/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-25573.html2026-03-07https://www.forpatients.roche.co.za/en/trials/eye-disorder.html2019-04-26https://www.forpatients.roche.co.za/en/trials/eye-disorder/dme.html2019-04-26https://www.forpatients.roche.co.za/en/trials/eye-disorder/glaucoma.html2019-04-26https://www.forpatients.roche.co.za/en/trials/eye-disorder/amd.html2026-02-23https://www.forpatients.roche.co.za/en/trials/eye-disorder/amd/a-study-to-evaluate-the-safety--tolerability--pharmacok-30793.htmlhttps://www.forpatients.roche.co.za/en/trials/eye-disorder/amd/a-study-to-evaluate-the-long-term-safety-and-tolerabili-60381.htmlhttps://www.forpatients.roche.co.za/en/trials/eye-disorder/wamd.html2019-04-26https://www.forpatients.roche.co.za/en/trials/muscle-and-peripheral-nerve-disease.html2019-04-26https://www.forpatients.roche.co.za/en/trials/muscle-and-peripheral-nerve-disease/sma.html2019-04-26https://www.forpatients.roche.co.za/en/trials/muscle-and-peripheral-nerve-disease/dmd.html2019-04-26https://www.forpatients.roche.co.za/en/trials/muscle-and-peripheral-nerve-disease/muscular-dystrophy.html2019-04-26https://www.forpatients.roche.co.za/en/trials/infectious-diseases/hbv.html2019-04-26https://www.forpatients.roche.co.za/en/trials/infectious-diseases/hbv/a-trial-to-evaluate-the-efficacy-and-safety-of-multiple-42976.htmlhttps://www.forpatients.roche.co.za/en/trials/infectious-diseases/influenza/study-to-assess-the-safety--pharmacokinetics--and-effic-62594.html2024-06-22https://www.forpatients.roche.co.za/en/trials/infectious-diseases/influenza/study-to-assess-the-efficacy-of-baloxavir-marboxil-vers-02272.html2024-09-01https://www.forpatients.roche.co.za/en/trials/infectious-diseases/bacterial-infection.html2019-04-26https://www.forpatients.roche.co.za/en/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-efficacy-and-safety-of-tocilizu-42486.html2024-08-30https://www.forpatients.roche.co.za/en/trials/infectious-diseases/covid-19-pneumonia/a-study-evaluating-tocilizumab-in-pediatric-patients-ho-36781.html2024-08-31https://www.forpatients.roche.co.za/en/trials/infectious-diseases/chronic-hepatitis-b.html2023-03-13https://www.forpatients.roche.co.za/en/trials/neurodegenerative-disorder/ad/a-study-of-crenezumab-versus-placebo-to-evaluate-the-efficacy-an.html2024-09-01https://www.forpatients.roche.co.za/en/trials/neurodegenerative-disorder/als.html2019-04-26https://www.forpatients.roche.co.za/en/trials/neurodegenerative-disorder/pd/a-study-to-investigate-the-safety--tolerability--pharma-25036.html2024-09-20https://www.forpatients.roche.co.za/en/trials/neurodegenerative-disorder/hd.html2019-04-26https://www.forpatients.roche.co.za/en/trials/neurodevelopmental-disorder.html2019-04-26https://www.forpatients.roche.co.za/en/trials/neurodevelopmental-disorder/autism-spectrum-disorder.html2019-04-26https://www.forpatients.roche.co.za/en/trials/psychiatric-disorder.html2019-04-26https://www.forpatients.roche.co.za/en/trials/psychiatric-disorder/schizophrenia.html2019-04-26https://www.forpatients.roche.co.za/en/trials/respiratory-disorder/ipf/efficacy--safety--and-tolerability-study-of-pirfenidone-in-combi.html2026-03-26https://www.forpatients.roche.co.za/en/trials/respiratory-disorder/ipf/a-study-evaluating-the-efficacy-and-safety-of-vixarelim-89139.html2025-03-27https://www.forpatients.roche.co.za/en/trials/respiratory-disorder/asthma/a-study-to-assess-the-efficacy-and-safety-of-mstt1041a--35784.html2024-06-21https://www.forpatients.roche.co.za/en/trials/respiratory-disorder/copd/a-study-to-evaluate-the-efficacy-and-safety-of-astegoli-91402.html2025-03-27https://www.forpatients.roche.co.za/en/trials/respiratory-disorder/copd/a-study-to-evaluate-astegolimab-in-participants-with-ch-57511.html2025-03-27https://www.forpatients.roche.co.za/en/trials/respiratory-disorder/copd/a-study-to-evaluate-the-long-term-safety-of-astegolimab-26646.html2025-03-27https://www.forpatients.roche.co.za/en/trials/healthy-volunteers.html2019-04-26https://www.forpatients.roche.co.za/en/trials/kidney-disorder.html2019-04-26https://www.forpatients.roche.co.za/en/trials/kidney-disorder/ckd.html2019-04-26https://www.forpatients.roche.co.za/en/trials/kidney-disorder/renal-failure.html2019-04-26https://www.forpatients.roche.co.za/en/trials/metabolic-disorder.html2019-04-26https://www.forpatients.roche.co.za/en/trials/metabolic-disorder/t1d.html2019-04-26https://www.forpatients.roche.co.za/en/trials/metabolic-disorder/t2d.html2019-04-26https://www.forpatients.roche.co.za/en/trials/metabolic-disorder/Liver_Failure.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cardiovascular-disorder.html2019-04-26https://www.forpatients.roche.co.za/en/trials/cardiovascular-disorder/AIS.html2019-04-26https://www.forpatients.roche.co.za/en/trials/hematologic-diseases/myelodysplastic-syndrome.html2019-04-26https://www.forpatients.roche.co.za/en/trials/hematologic-diseases/Hemophilia/a-study-of-emicizumab-administered-subcutaneously--sc---47981.html2024-08-30https://www.forpatients.roche.co.za/en/trials/hematologic-diseases/Hemophilia/a-clinical-trial-to-evaluate-prophylactic-emicizumab-ve-59481.html2024-08-31https://www.forpatients.roche.co.za/en/trials/hematologic-diseases/Hemophilia/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-78611.html2024-08-31https://www.forpatients.roche.co.za/en/trials/hematologic-diseases/Hemophilia/hemophilia-a.html2023-05-10https://www.forpatients.roche.co.za/en/trials/blood-disorder/sickle-cell-disease/a-study-evaluating-the-efficacy--safety--pharmacokineti-50959.html2026-03-24https://www.forpatients.roche.co.za/en/trials/blood-disorder/sickle-cell-disease/a-study-evaluating-the-safety--pharmacokinetics--pharma-03990.html2025-03-27https://www.forpatients.roche.co.za/en/faq.html2023-05-09https://www.forpatients.roche.co.za/en/faq/what-is-a-clinical-trial.html2023-05-09https://www.forpatients.roche.co.za/en/faq/why-should-i-consider-taking-part-in-a-clinical-trial.html2023-04-13https://www.forpatients.roche.co.za/en/faq/roche-in-clinical-trials.html2023-05-09https://www.forpatients.roche.co.za/en/faq/advancing-inclusive-research.html2023-04-12https://www.forpatients.roche.co.za/en/faq/what-is-an-observational-trial.html2023-04-12https://www.forpatients.roche.co.za/en/error.html2019-04-26https://www.forpatients.roche.co.za/en/error/404.html2024-11-11https://www.forpatients.roche.co.za/en/error/403.html2024-11-11https://www.forpatients.roche.co.za/en/error/500.html2024-11-11https://www.forpatients.roche.co.za/en/privacy-policy.html2019-04-26https://www.forpatients.roche.co.za/en/About.html2019-04-26https://www.forpatients.roche.co.za/en/sitemap.html2019-04-26https://www.forpatients.roche.co.za/en/covid-19.html2023-04-12https://www.forpatients.roche.co.za/en/disease-area-overview.html2020-08-06https://www.forpatients.roche.co.za/en/solr-results.html2022-09-20https://www.forpatients.roche.co.za/en/new-solr-search.html2024-02-14